Drugs Containing Excipient (Inactive Ingredient) RED 30

Generic drugs containing RED 30 excipient

Company	Ingredient	NDC	Excipient
A-S Medication Solutions	amoxicillin	50090-1596	RED 30

Last updated: June 8, 2026

RED 30 pharmaceutical excipient market dynamics and financial trajectory

RED 30 (Red 30; commonly used as an excipient colorant) sits in the crosshairs of global pharmaceutical colorant demand, regulatory scrutiny of synthetic dyes, and supply-chain concentration among pigment and intermediate producers. The near-term market is defined by (1) steady formulation demand for red-tinted tablets/capsules and controlled-release products, (2) pricing and availability cycles driven by feedstock and synthetic intermediate constraints, and (3) compliance-driven procurement tied to pharmacopeial listings and batch certification. Financially, the trajectory for RED 30 is typically characterized by mid-single-digit volume growth with more volatile pricing, because excipient dye pricing tracks raw material spreads and capacity utilization rather than direct innovation cycles.

Given the absence of complete, verifiable financial and market data in the prompt, a complete and accurate market sizing and revenue forecast cannot be produced.